title: PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering.
authors: l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, Nantes, France. Electronic address: bertrand.cariou@univ-nantes.fr.
authors: Bertrand
authors: B
authors: Cariou
authors: Central Arkansas Veterans Helthcare System, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors: Zufeng
authors: Z
authors: Ding
authors: Central Arkansas Veterans Helthcare System, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: mehtajl@uams.edu.
authors: Jawahar L
authors: JL
authors: Mehta
mesh_terms: D050197:Atherosclerosis; D008078:Cholesterol, LDL; D006801:Humans; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D011973:Receptors, LDL; D012694:Serine
chemical_list: D008078:Cholesterol, LDL; D011973:Receptors, LDL; D012694:Serine; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases
keywords: Atherosclerosis; Coronary restenosis; Extra-hepatic; PCSK9; Vascular smooth muscle cell